Woodline Partners’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$165K | – | 676 |
|
|
2023
Q4 | $165K | Hold |
10,000
| – | – | ﹤0.01% | 461 |
|
|
2023
Q3 | $77.3K | Hold |
10,000
| – | – | ﹤0.01% | 576 |
|
|
2023
Q2 | $52.1K | Hold |
10,000
| – | – | ﹤0.01% | 614 |
|
|
2023
Q1 | $53.7K | Buy |
+10,000
| New | +$54.4K | ﹤0.01% | 614 |
|
|
2022
Q1 | – | Sell |
-36,174
| Closed | -$477K | – | 857 |
|
|
2021
Q4 | $477K | Hold |
36,174
| – | – | 0.01% | 557 |
|
|
2021
Q3 | $832K | Buy |
+36,174
| New | +$1.08M | 0.01% | 525 |
|
|
2021
Q2 | – | Sell |
-5,630
| Closed | -$409K | – | 652 |
|
|
2021
Q1 | $409K | Sell |
5,630
-67,916
| -92% | -$4.82M | 0.01% | 399 |
|
|
2020
Q4 | $3.18M | Buy |
73,546
+56,855
| +341% | +$2.55M | 0.08% | 178 |
|
|
2020
Q3 | $686K | Sell |
16,691
-12,534
| -43% | -$648K | 0.02% | 175 |
|
|
2020
Q2 | $1.75M | Sell |
29,225
-29,900
| -51% | -$2.74M | 0.07% | 136 |
|
|
2020
Q1 | $4.45M | Buy |
59,125
+47,849
| +424% | +$5.51M | 0.32% | 93 |
|
|
2019
Q4 | $1.55M | Buy |
+11,276
| New | +$1.37M | 0.06% | 102 |
|
Woodline Partners's ORTX Position: Q1 2024 in Review
Woodline Partners sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 10,000 shares — an estimated $165K sold.
Woodline Partners first reported a position in ORTX in Q4 2019 and held it in 12 quarters. The position peaked at $4.45M in Q1 2020. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- Woodline Partners reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Woodline Partners sold 10,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $165K.
- Woodline Partners first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 12 quarters.
- Woodline Partners's Orchard Therapeutics plc American Depositary Shares position peaked at $4.45M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.